Endogenous PYY and GLP-1 mediate l -glutamine responses in intestinal mucosa

British Journal of Pharmacology

Volumn 170, Issue 5, 2013, Pages 1092-1101

  Joshi, S ^a   Tough, I R ^a   Cox, H M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

calcium sensing receptor; endogenous peptide YY; enteroendocrine L cell; mucosal ion transport; PYY mice; Y1 receptor

Indexed keywords

CALCIUM SENSING RECEPTOR; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; GLUTAMINE; MANNITOL; PEPTIDE YY;

ANIMAL TISSUE; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; INTESTINE MUCOSA; JEJUNUM MUCOSA; MALE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; VOLTAGE CLAMP;

CALCIUM-SENSING RECEPTOR; ENDOGENOUS PEPTIDE YY; ENTEROENDOCRINE L-CELL; MUCOSAL ION TRANSPORT; PYY-/- MICE; Y1 RECEPTOR;

ANIMALS; COLON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUTAMINE; HORMONE ANTAGONISTS; INTESTINAL MUCOSA; JEJUNUM; MALE; MEMBRANE POTENTIALS; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; PARACRINE COMMUNICATION; PEPTIDE YY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GLUCAGON; RECEPTORS, NEUROPEPTIDE Y;

EID: 84885604147     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12352     Document Type: Article

References (44)

1. Alexander SPH, Mathie A, Peters JA, (2011). Guide to receptors and channels (GRAC). 5th edn. Br J Pharmacol 164 (Suppl.1): S1-S324.
2. Anini Y, Fu-Cheng X, Cuber JC, Kervran A, Chariot J, Roze C, (1999). Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat. Pflugers Arch 438: 299-306.
3. Astrup A, Carraro R, Finer N, Harper A, Kunesova M, Lean MEJ, et al. (2012). Safety, tolerability and sustained weight loss over 2 years with a once-daily human GLP-1 analogue, liraglutide. Int J Obes (Lond) 36: 843-854.
4. Boey D, Lin S, Karl T, Baldock P, Lee N, Enriquez R, et al. (2006). Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity. Diabetologia 49: 1360-1370.
5. Boey D, Sainsbury A, Herzog H, (2007). The role of peptide YY in regulating glucose homeostasis. Peptides 28: 390-395.
6. Böttcher G, Sjölund K, Ekblad E, Håkanson R, Schwartz TW, Sundler F, (1984). Co-existence of PYY and glicentin in endocrine cells of the gut. Regul Pept 8: 261-266.
7. Chronaiou A, Tsoli M, Kehagias I, Leotsinidis M, Kalfarentzos F, Alexandrides TK, (2012). Lower ghrelin levels and exaggerated postprandial PYY, GLP-1 and insulin responses after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial. Obes Surg 22: 1761-1770.
8. Chu Z-L, Carroll C, Alfonson J, Guierrez V, He H, Lucman A, et al. (2008). A role for intestinal endocrine cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release. Endocrinology 149: 2038-2047.
9. 4 receptors mediate Y agonist responses in isolated human colon mucosa. Br J Pharmacol 135: 1505-1512.
10. Cox HM, Pollock EL, Tough IR, Herzog H, (2001). Multiple Y receptors mediate pancreatic polypeptide responses in mouse colon mucosa. Peptides 22: 445-452.
11. Cox HM, Tough IR, Woolston AM, Zhang L, Nguyen AD, Sainsbury S, et al. (2010). Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses. Cell Metab 11: 532-542.
12. Dirksen C, Damgaard M, Bojsen-Moller KN, Jorgensen NB, Kielgast U, Jacobsen SH, et al. (2013). Fast pouch emptying, delayed small intestinal transit and exaggerated gut hormone responses after Roux-en-Y gastric bypass. Neurogastroenterol Motil 25: 346-e255. doi: 10.1038/ijo.2013.15. [Epub ahead of print].
13. Drucker DJ, (2005). Biologic actions and therapeutic potential of the proglucagon-derived peptides. Nat Clin Pract Endocrinol Metab 1: 22-31.
14. Egerod KL, Engelstoft MS, Grunddal KV, Nohr MK, Secher A, Sakata I, et al. (2012). A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY and neurotensin but not somatostatin. Endocrinology 153: 5782-5795.
15. Engelstoft MS, Egerod KL, Holst B, Schwartz TW, (2008). A gut feeling of obesity: 7TM sensors on enteroendocrine cells. Cell Metab 8: 447-449.
16. 2+-sensing receptor along the gastrointestinal tract. Annu Rev Physiol 71: 205-217.
17. Greenfield JR, Farooqi IS, Keogh JM, Henning E, Habib AM, Blackwood A, et al. (2009). Oral glutamine increases circulating glucagon-like peptide 1, glucagon and insulin concentrations in lean, obese, and type 2 diabetic subjects. Am J Clin Nutr 89: 106-113.
18. Habib AM, Richards P, Cairns LS, Roger GJ, Bannon CAM Parker HE, et al. (2012). Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry. Endocrinology 153: 3054-3065.
19. Holst JJ, (2007). The physiology of glucagon-like peptide 1. Physiol Rev 87: 1409-1439.
20. Holst JJ, (2013). Incretin hormones and the satiation signal. Int J Obes (Lond) 37: 1161-1168. doi: 10.1038/ijo.2012.208. [Epub ahead of print].
21. 2 antagonism in mouse and human colonic tissues. Br J Pharmacol 139: 863-871.
22. Karl T, Duffy L, Herzog H, (2008). Behavioural profile of a new mouse model for NPY deficiency. Eur J Neurosci 28: 173-180.
23. Ku SK, Lee HS, Lee JH, (2003). An immunohistochemical study of the gastrointestinal endocrine cells in C57BL/6 mice. Anat Histol Embryol 32: 21-28.
24. Liou AP, Sei Y, Zhao X, Feng J, Lu X, Thomas C, et al. (2011). The extracellular calcium-sensing receptor is required for cholecystokinin secretion in response to L-phenylalanine in acutely isolated intestinal I cells. Am J Physiol Gastrointest Liver Physiol 300: G538-G546.
25. Mace OJ, Schindler M, Patel S, (2012). The regulation of K- and L-cell activity bu GLUT2 and the calcium-sensing receptor CaSR in rat small intestine. J Physiol 590: 2917-2936.
26. Nemeth EF, Steffey ME, Hammerland LG, Hung BCP, Van Wagenen BC, DelMar EG, et al. (1998). Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci U S A 95: 4040-4045.
27. Oshima H, Yoshida S, Ohishi T, Matsui T, Tanaka H, Yonetoku Y, et al. (2013). Novel GPR119 agonist AS1669058 potentiates insulin secretion from rat islets and has potent anti-diabetic effect in ICR and diabetic db/db mice. Life Sci 92: 167-173.
28. Overton HA, Fyfe MCT, Reynet C, (2008). GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity. Br J Pharmacol 153: 576-581.
29. Pedersen J, Ugleholdt RK, Jorgensen SM, Windelov JA, Grunddal KV, Schwartz TW, et al. (2012). Glucose metabolism is altered after loss of L cells and α cells but not influenced by loss of K cells. Am J Physiol Endocrinol Metab 304: E60-E73.
30. 2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain. J Biol Chem 279: 18990-18997.
31. Rasschaert J, Malaisse WJ, (1999). Expression of the calcium-sensing receptor in pancreatic islet β-cells. Biochem Biophys Res Commun 264: 615-618.
32. Ray JM, Squires PE, Curtis SB, Meloche MR, Buchan AM, (1997). Expression of the calcium-sensing receptor on human antral gastrin cells in culture. J Clin Invest 99: 2328-2333.
33. Reimann F, Williams L, Xavier G, Rutter GA, Gribble FM, (2004). Glutamine potently stimulates glucagon-like peptide-1 secretion fro GLUTag cells. Diabetologia 47: 1592-1601.
34. Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ, Gribble FM, (2008). Glucose sensing in L cells: a primary cell study. Cell Metab 8: 532-539.
35. Reimann F, Tolhurst G, Gribble FM, (2012). G-protein-coupled receptors in intestinal chemosensation. Cell Metab 15: 421-431.
36. Rhoads JM, Wu G, (2009). Glutamine, arginine, and leucine signaling in the intestine. Amino Acids 37: 111-122.
37. Samocha-Bonet D, Wong O, Synnott EL, Piyaratna N, Douglas A, Gribble FM, et al. (2011). Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in Type 2 diabetic patients. J Nutr 141: 1233-1238.
38. Savage AP, Adrian TE, Carolan G, Chaterjee VK, Bloom SR, (1987). Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut 28: 166-170.
39. Sheinin Y, Kallay E, Wrba F, Kriwanek S, Peterlik M, Cross HS, (2000). Immunocytochemical localization of the extracellular calcium-sensing receptor in normal and malignant human large intestinal mucosa. J Histochem Cytochem 48: 595-601.
40. 2+ and cAMP. Endocrinology 152: 405-413.
41. 4 receptors mediate the inhibitory responses of pancreatic polypeptide in human and mouse colon mucosa. J Pharmacol Exp Ther 319: 20-30.
42. 2 receptors. Br J Pharmacol 164: 66-79.
43. 1 receptor antagonist BIBO3304 and its effect on feeding in rodents. Br J Pharmacol 125: 549-555.
44. Wilmore DW, (2001). The effect of glutamine supplementation in patients following elective surgery and accidental injury. J Nutr 131: 2543S-2549S.